Initial Clinical Experience With A Novel Spectroscopy Catheter That Can Identify Lipid-core Coronary Plaques

There is an unmet need for a method to identify lipid-core coronary plaques, the structures associated with most heart attacks and not detectable by conventional coronary angiography. On April 25, 2008 the U. S. FDA granted clearance to InfraReDx, Inc. for marketing of its LipiScan(TM) System to identify lipid core containing coronary plaques. Dr.

More: continued here

Filed under: Blood on October 13th, 2008